Navigation Links
PharmMD's Brad Tice to Receive Distinguished Achievement Award
Date:3/12/2010

NASHVILLE, Tenn., March 12 /PRNewswire/ -- Brad Tice, Pharm.D., Chief Clinical Officer of PharmMD, will receive the 2010 APhA-APPM Distinguished Achievement Award in Clinical/Pharmacotherapeutic Practice during the Second General Session at APhA 2010, the annual meeting of the American Pharmacists Association (APhA) to be held in Washington, D.C. on March 12-15, 2010.

The award recognizes the achievements of an individual who has made a significant contribution or sustained contributions to the provision of pharmaceutical care within the clinical/pharmacotherapeutic practice.  

Pharmaceutical care, now called Medication Therapy Management (MTM), refers to the process of preventing drug errors, overuse and abuse by ensuring that individual patients receive the most appropriate medications possible.  Dr. Tice was a member of the team that wrote the accepted clinical definition of MTM approved by 11 organizations, including the APhA.  He also participated on the advisory panel that developed the MTM model jointly issued by APhA and National Association of Chain Drug Stores (NACDS).

As evidence of the increasing value and importance of MTM, in 2006, the Centers for Medicare and Medicaid Services (CMS) began requiring each sponsor of its Part D drug benefits to incorporate an MTM program into their plan's benefit structure.  CMS leadership has referred to MTM as the "cornerstone" of the Part D Medicare benefit.  

Dr. Tice currently serves as Chief Clinical Officer for PharmMD, an MTM provider that works with employers, government plans and other payers to prevent harmful drug interactions and provide better drug therapy outcomes at a lower cost.  Dr. Tice has led the development of the documentation and analytics platform that PharmMD pharmacists use to deliver services, including the development of the CPL, Clinical Programming Language, to enable pharmacists to improve care at the population level and measure the results of their services.

"Dr. Tice has a passion for patient care and improving the quality of medication therapies.  This award is evidence of his leadership as a pharmacist," said Bo Bartholomew, founder and CEO of PharmMD.

As a member of the APhA Academy of Pharmacy Practice and Management, Dr. Tice has held numerous leadership positions, including Member-At-Large of the Executive Committee and Chair of the Clinical/Pharmacotherapeutic section.  In 2008, Dr. Tice was named a fellow of the American Pharmacists Association and for several years he sat on the Advisory Board of the Journal of the American Pharmacists Association.  Tice served as Speaker of the House, Vice-Speaker and Member of the Board of Trustees of the Iowa Pharmacists Association and has also been actively involved in the Pharmacy Quality Alliance (PQA), currently serving as the Co-Chair of its Quality Metrics Workgroup and the Technical Expert Panel advising CMS on Medication Measures.

Dr. Tice began his pharmacy career focusing on the delivery of patient care services for Osco Drug, first as a pharmacist in Kansas City, Kan., and later as a pharmacy manager for Osco Drug in Davenport, Iowa.  He later became an assistant and associate professor at the Drake University College of Pharmacy and Health Sciences and Director of the Osco Drug/Drake University Community Care Laboratory.  Dr. Tice earned his Bachelors of Science and Doctorate in pharmacy from the University of Kansas.  

Dr. Tice was awarded the Iowa Pharmacy Association Young Pharmacist of the Year in

2001 and the 2005 Alfred B. Prescott/GlaxoSmithKline Leadership Award.

About PharmMD

PharmMD is the quality leader in Medication Therapy Management Solutions.  Based in Brentwood, Tenn., PharmMD works with employers and health plans to prevent medication related health problems through the application of the best pharmacist and physician knowledge using their proprietary MTM software.  Founded in 2006, PharmMD improves coordination and communication among physicians, pharmacists, payers and patients by analyzing pharmacy and medical claims information and clinical decision making. Because PharmMD focuses exclusively on MTM, the company is able to analyze both aggregate and patient-specific data to identify trends and conflicts to positively impact patient health and contain costs. More information at:

www.pharmmd.com.  

About the American Pharmacists Association (APhA)

The American Pharmacists Association is dedicated to improving medication use and advancing patient care.  APhA's awards and recognition program is American Pharmacy's most comprehensive recognition program. Founded in 1852 as the American Pharmaceutical Association, APhA is the first-established and largest professional association of pharmacists in the United States.  Its more than 62,000 members include pharmacists, scientists, student pharmacists, pharmacy technicians and others interested in advancing the profession.

SOURCE PharmMD

Back to top

RELATED LINKS
http://www.pharmmd.com

'/>"/>

SOURCE PharmMD
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... CHAPEL HILL, N.C. , Feb. 5, 2016 /PRNewswire/ ... sector has been slower than other industries to embrace ... that come with utilization. On the medical side, organizations ... to improve everything from clinical trials to adherence. ... recent research from benchmarking firm Best Practices, LLC, Big ...
(Date:2/5/2016)... , Feb. 5, 2016 Amgen (NASDAQ: ... Annual Global Healthcare Conference at 9:15 a.m. ET on ... . David W. Meline , executive vice president ... conference. Live audio of the presentation can be accessed from ... Investors. A replay of the webcast will also be available ...
(Date:2/5/2016)...  Redwood Scientific Technologies, Inc. announced today the development ... women balance their hormones. This product will be featuring ... Jason Cardiff , President and CEO. "I am proud ... millions of women across the country and around the ... Our research and development team is confident that through ...
Breaking Medicine Technology:
(Date:2/7/2016)... Michigan (PRWEB) , ... February 07, 2016 , ... ... organ prolapse with the latest techniques and the most minimally invasive approaches. , ... organ prolapse, particularly after menopause. Other risk factors include surgery to the pelvic ...
(Date:2/7/2016)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... February 07, ... ... women on Friday in recognition of National Wear Red Day. National Wear Red ... heart disease and stroke in women. Heart disease and stroke cause 1 in 3 ...
(Date:2/7/2016)... ... February 07, 2016 , ... HealthSmart Holdings, Inc. ... organizations with the tools and information to lower the costs, and increase the ... cost of providing employee healthcare benefits by as much as 22%:, + ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... Plastics, has added Kybella® to his medical and surgical expertise. Technically known as ... FDA injectable medication used as a non-surgical alternative for reduction of fat below ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , This conference ... estimated 5000 perioperative nurses in attendance to study the latest evidence-based recommendations ...
Breaking Medicine News(10 mins):